Swedish serum for smoking cessation

Swedish Medical Institute successfully followed a medical trading company in Stockholm to reach medical help serum smoker to quit smoking according to a logical time gradually, and will be in commercial markets serum as soon as it determines its success on the volunteers who wish to refrain from smoking.

The report issued by the Institute of the tests on the serum gave positive results and reassuring, explaining that the vaccine will help the smoker to refrain in record time.
He explained that the vaccine depends mainly on dealing with the immune system in the body, as the serum consists of a protein that activates and activate immune body smoker to prevent the arrival of nicotine into the brain, and this will prevent thus brain secretion of material that forces the body to request nicotine addiction.
Musharraf through medical operations in the company of Thomas Larson hoped serum to find his way to the market soon, adding that laboratory tests on mice have proven success rate of 100%.
Larson stressed that the vaccine being tested on a number of volunteers who wish to refrain from smoking, pointing out that the initial results promising and reassuring. He added that once proven successful in humans will the company to put it to the consumer markets, and if that happens, the serum will be considered as a quantum leap in the field of laboratory medicine and science involved with drugs.
Larson explained that the vaccine did not leave side effects on the psychology of mice or Tabaaha, saying it is free of any side effects on the smoker when used to stop smoking. He added that the most important thing can achieve serum along with distance from the side effects of treatment is removed from the high costs incurred by states and governments to raise awareness and counseling for smoking cessation, stressing that there is no need for any of the sessions advice or follow-up psychological only in how to use the serum and method .

-->